New patent expiration for Xspire Pharma drug ZONTIVITY
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. […]
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
Patent Expiration
New patent expiration for Cephalon drug NUVIGIL
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It
New patent expiration for Cephalon drug PROVIGIL
Annual Drug Patent Expirations for PROVIGIL Provigil is a drug marketed by Cephalon and is included in one NDA. It
New patent expiration for Cephalon drug PROVIGIL Read Post »
New patent expiration for Abbvie drug ACULAR LS
Annual Drug Patent Expirations for ACULAR+LS Acular Ls is a drug marketed by Abbvie and is included in one NDA.
Drug Patent Expirations for the Week of May 26, 2024
ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of May 26, 2024 Read Post »
New patent expiration for Novartis Pharms drug ENTRESTO
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one
New patent expiration for Novartis Pharms drug ENTRESTO Read Post »
New patent expiration for ZYLA drug OXAYDO
Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It
New patent expiration for Haleon Us drug CHILDREN’S ADVIL-FLAVORED
Annual Drug Patent Expirations for CHILDREN%27S+ADVIL-FLAVORED For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
New patent expiration for Haleon Us drug CHILDREN’S ADVIL-FLAVORED Read Post »
New patent expiration for Galderma Labs drug MIRVASO
Annual Drug Patent Expirations for MIRVASO Mirvaso is a drug marketed by Galderma Labs Lp and is included in one
New patent expiration for Galderma Labs drug MIRVASO Read Post »
